Skip to main content

Julie Rhoads, Ph.D.


Dr. Rhoades’ laboratory focuses on tumor-induced bone disease using molecular biology and pre-clinical approaches to identify novel therapeutic targets for reducing tumor growth and bone destruction. She is an Associate Professor in the Department of Medicine in the Division of Clinical Pharmacology with appointments the Program in Cancer Biology, Pharmacology, and Biomedical Engineering graduate programs.